Literature DB >> 19281885

Common microbial pathogens in surgical practice.

Motaz Qadan1, William G Cheadle.   

Abstract

Despite ongoing major advances in antisepsis and in the development of potent antimicrobial agents since the early twentieth century, human beings remain subject to bacterial and fungal infection through mechanisms of virulence that continue to evade the latest advents in the microbiologic field today. Infection persists in surgical patients and only via the procurement of an in-depth knowledge of microorganism evolution and progression and an intricate understanding of human immune defense mechanisms are surgeons able to tackle infection in a fashion synonymous to that which allowed historic legends to transform the mere concept of surgery into reality. This article broadly describes current microbial pathogens and related issues in surgical disease.

Entities:  

Mesh:

Year:  2009        PMID: 19281885     DOI: 10.1016/j.suc.2008.09.002

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  2 in total

1.  Simple multiplex PCR assays to detect common pathogens and associated genes encoding for acquired extended spectrum betalactamases (ESBL) or carbapenemases from surgical site specimens in Vietnam.

Authors:  Ngo Tat Trung; Tran Thi Thu Hien; Tran Thi Thanh Huyen; Dao Thanh Quyen; Mai Thanh Binh; Phan Quoc Hoan; Christian G Meyer; Thirumalaisamy P Velavan; Le Huu Song
Journal:  Ann Clin Microbiol Antimicrob       Date:  2015-04-12       Impact factor: 3.944

2.  Significance of nucleic acid testing in diagnosis and treatment of post-neurosurgical meningitis caused by multidrug-resistant Acinetobacter baumannii: a case report.

Authors:  Ngo Tat Trung; Trinh Van Son; Dao Thanh Quyen; Dang Thi Viet Anh; Vu Viet Sang; Nguyen Xuan Lam; Nguyen Dang Manh; Vuong Phuc Duong; Bui Tri Cuong; Quyen Dang Tuyen; Nguyen Xuan Chinh; Phan Quoc Hoan; Hoang Van Tong; Christian G Meyer; Le Huu Song
Journal:  J Med Case Rep       Date:  2016-11-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.